Curating from trusted global sources…
32 briefings · “dea”
China biotech deals with major multinationals surged to US$75 billion in 2026’s first five months, up from zero before 2020.
Award-winning producer David DeHaney says the dealmaking risk got too high, and trading is ending with an administrator.
A new hackathon pushes developers to build offline AI tools in local languages, reshaping where AI innovation can originate.
After about 14 months of talks, the South Korea theatrical giant plan dies, shifting leverage across the exhibition market.
If the US takes a slice, it may turn a long-discussed negotiation into a tech-industry template for security and oversight.
A Central African project shows what happens when U.S. priorities collide with local realities and policy limits.
The deputy foreign minister says Tehran will tap some frozen assets in Qatar to buy needed goods under the Iran-US deal.
A $4 million defamation win in 2022 spawned a deal, and Cardi says the blogger broke it.
Hospital samples from decades ago reveal how resistance tightened gradually, then surged, with global implications for infection control.
Without extending USMCA, automakers may lose trade advantages tied to where parts are made.
Power, permits, customer non-payment, and renewal risk could turn Oracle’s AI bet into a long-term liability.
In a new Q&A, Hideaki Nishino and Sony leadership pitch peripherals and “usage styles” as a PC-adjacent expansion.
